US Patent 9770512 Methods to induce targeted protein degradation through bifunctional molecules
Patent 9770512 was granted and assigned to Dana-Farber Cancer Institute on September, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9770512 Methods to induce targeted protein degradation through bifunctional molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.